Correction: Converting an immunologically “cold” tumor: Exceptional response to cadonilimab plus chemotherapy in microsatellite-stable pancreatic cystadenocarcinoma

• by Chunxiao Ni, Jiaju Xu, Yu Pang

• June 10, 2026

Precision Diagnostics and the ADC Revolution

Antibody-drug conjugates are transforming cancer care, but their success depends on more precise, sensitive, and data-driven diagnostics

• June 10, 2026

• 15 min

Hetairos is a histology-based artificial intelligence model for predicting central nervous system tumor methylation subtypes

• by Darui Jin, Artem Shmatko, Areeba Patel, Samuel Rutz, Lukas Friedrich, Rouzbeh Banan, Ramin Rahmanzade, Philipp Sievers, Stefan Hamelmann, Daniel Schrimpf, Kirsten Göbel, Henri Bogumil, Sybren L. N. Maas, Martin Sill, Felix E. Hinz, Abigail K. Suwala, Felix Keller, Antje Habel, Gleb Rukhovich, Ferdinand Zettl, Obada T. Alhalabi, Sebastian Ille, Jannik Sehring, Daniel Amsel, Benedikt Wiestler, Pedro Piovesan Lago, Bogdana Suchorska, Olfat Ahmad, Dominik Sturm, David Reuss, Pieter Wesseling, Adelheid Wöhrer, Frank L. Heppner, Ingmar Blümcke, Claire Delbridge, Martin Jakobs, Christel Herold-Mende, Sandro M. Krieg, Wolfgang Wick, David T. W. Jones, Stefan M. Pfister, Maysa Al-Hussaini, Yanghao Hou, Felipe D’Almeida Costa, Leonille Schweizer, Luca Bertero, Till Acker, Arnault Tauziede-Espariat, Pascale Varlet, Doron Merkler, Kristof Egervari, Hildegard Dohmen, Pablo Zoroquiain, Roger Gejman, Sebastian Brandner, Xiangzhi Bai, Andreas von Deimling, Felix Sahm, Moritz Gerstung

• June 10, 2026

Development and validation of a multiparametric MRI-based radiomics nomogram for the tripartite discrimination of primary benign, primary malignant, and metastatic lumbar spinal tumors

• by Canghai Shen, Shuai Yang, Xi Chen, Yongjian Feng, Yancheng Song, Jianxi Zhou, Yunchuan Sun

• June 10, 2026